Medical oncologist Heather Parsons, MD, MPH, witnessed how cancer affects the entire family when her younger sister was ...

Updated indication allows the use of RINVOQ® (upadacitinib) prior to the use of tumor necrosis factor (TNF) blocking agents in patients for whom ...

Severe gastrointestinal inflammation could occur in 2 percent to 3 percent of patients who receive Carvykti, the FDA has informed patients and doctors.

After undergoing treatment for Stage 2 Hodgkins lymphoma, Hardee Bhavsar is on a journey to cross items off her bucket list ...

FDA updates Johnson & Johnson's Carvykti label to warn of rare immune-related enterocolitis while reaffirming the therapy's ...

Bristol Myers BMY recently announced that it will acquire privately held biotechnology company Orbital Therapeutics for $1.5 billion in cash. The acquisition will add OTX-201, an investigational ...

BeOne Medicines said the Food and Drug Administration has granted Breakthrough Therapy Designation for sonrotoclax for the treatment of adult patients with relapsed or refractory mantle cell lymphoma.

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation ...

Primary results from the Phase III evERA Breast Cancer study, the first positive head-to-head Phase III trial investigating an all-oral selective estrogen receptor (ER) degrader-containing regimen ...

Every year, more than 80,000 Americans hear the life-changing words: You have Non-Hodgkin’s Lymphoma. That may not sound like a lot — until you realize it’s the entire population of ...

This research is still in the early stages, but it provides an exciting look at how cancer treatment could evolve. If future ...

George Stewart prefers to be out cycling on the roads of Fox Chapel, Indiana Township, West Deer and Butler County. Stewart, ...